logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Time trends in the treatment of acute myocardial infarction in Switzerland from 1986 to 1993 : Do they reflect the advances in scientific evidence from clinical trials ?

    Article - En anglais

    Three acute coronary care surveys (1986,1990, and 1993) were conducted in the Swiss region of Vaud-Fribourg on all men aged 25 to 64 years hospitalized for a definite myocardial infarction (218,224, and 167 cases).

    Nearly all patients received anticoagulants and nitrates.

    The proportion of patients treated increased significantly, between 1986 and 1990, for antiplatelet drugs (from 51% to 96%) and thrombolytics (from 9% to 44%) and, between 1990 and 1993, for beta-blockers (from 57% to 78%) and angiotensin-converting enzyme inhibitors (from 26% to 43%). The use of calcium antagonists and antiarrhythmics dropped over time.

    Coronary arteriography and angioplasty were increasingly performed (53% and 18% in 1993), although progressively postponed in-hospital stay.

    The observed trends reflect a rapid translation of clinical trials into medical practice.

    However the use of thrombolytics could be raised further by shortening the hospitalization delay (median : 3 hours in 1993) and door-to-needle time (median : 47 minutes) which remained stable over time.

    Mots-clés Pascal : Infarctus, Myocarde, Evolution, Variation temporelle, Epidémiologie, Chimiothérapie, Traitement, Efficacité traitement, Homme, Suisse, Europe, Appareil circulatoire pathologie, Cardiopathie coronaire, Myocarde pathologie

    Mots-clés Pascal anglais : Infarct, Myocardium, Evolution, Time variation, Epidemiology, Chemotherapy, Treatment, Treatment efficiency, Human, Switzerland, Europe, Cardiovascular disease, Coronary heart disease, Myocardial disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0453495

    Code Inist : 002B12A03. Création : 25/01/1999.